Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Sep-Oct;66(5):530-4.
doi: 10.1016/j.ihj.2014.08.012. Epub 2014 Oct 7.

Clopidogrel resistance: the way forward

Shuvanan Ray  1
Affiliations
Review

Clopidogrel resistance: the way forward

Shuvanan Ray. Indian Heart J. 2014 Sep-Oct.

Abstract

Clopidogrel, a second generation thienopyridine has been the mainstay of ACS (Acute Coronary Syndrome) treatment for more than a decade. Clopidogrel Resistance has been associated with increased mortality in ACS patients with an increase in number of Stent Thrombosis. This review article tries to find out the causes of Clopidogrel Resistance, the main factors involving it, Laboratory evaluation of Clopidogrel Resistance. The overall incidence of Clopidogrel Resistance across the Globe & India has also been considered. The article also discusses the clinical significance of Clopidogrel Resistance & its relationship with adverse cardiovascular events. This review ends with the probable solutions to Clopidogrel Resistance & the new generation of antiplatelets which can be used for the same.

Keywords: Clopidogrel resistance; Platelet reactivity; Prasugrel; Stent thrombosis; Ticagrelor.

PubMed Disclaimer

References

    1. Ding Z., Kim S., Dorsam R.T., Jin J., Kunapuli S.P. Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270. Blood. 2003;101:3908–3914. - PubMed
    1. CAPRIE Streeing Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348:1329–1339. - PubMed
    1. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., Fox K.K., Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Eng J Med. 2001;345:494–502. - PubMed
    1. Gurbel Paul A., Tantry Udaya S. Clopidogrel resistance? Thromb Res. 2007;120:311–321. Epub 2006 Nov 14. - PubMed
    1. Angiolillo D.J., Fernandez-Ortiz A., Bernardo E. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol. 2007 Apr 10;49:1505–1516. - PubMed

MeSH terms